Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Ligand Pharm (NQ: LGND )

119.19 +2.64 (+2.27%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 22, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Ligand Pharm

< Previous 1 2 3 4 5 6 Next >
What To Know About Rand Paul Failing To Disclose Gilead Stock Purchase For 16 Months
Stock transactions by members of the U.S. Congress and their spouses have been a hot topic over the last several years. A transaction disclosed late Wednesday is drawing heavy... 
Via Benzinga
Ligand Pharmaceuticals Incorporated (LGND) Q2 2021 Earnings Call Transcript
LGND earnings call for the period ending June 30, 2021. 
Via The Motley Fool
Topics Earnings
Exposures Financial
Ligand Reports Second Quarter 2021 Financial Results
From Ligand Pharmaceuticals Incorporated
Via Business Wire
Ligand Partner Jazz Pharmaceuticals Launches RYLAZE™ (asparaginase erwinia chrysanthemi (recombinant)-rywn), Formerly JZP458
From Ligand Pharmaceuticals Incorporated
Via Business Wire
The Daily Biotech Pulse: Merck's Disappointing Q2, Atreca Falls On Data, FDA Nod For Viatris, Nuvalent, Icosavax IPOs
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 28) AbbVie Inc. (NYSE: ABBV)... 
Via Benzinga
Exposures Product Safety
The Week Ahead In Biotech (July 25-31): Big Pharma Earnings, Iterum FDA Decision, Alzheimer's Conference, IPOs and More
Biotech stocks rebounded in the week ended July 23, thanks to the broader market strength. The sector also benefitted from the optimism that was set in motion by the solid start... 
Via Benzinga
Exposures Product Safety
Ligand’s Partner Merck Receives FDA Approval for VAXNEUVANCE™ for the Prevention of Invasive Pneumococcal Disease in Adults Caused by 15 Serotypes
From Ligand Pharmaceuticals Incorporated
Via Business Wire
The Week Ahead In Biotech: Earnings Kickstart With J&J And Biogen, Albireo Awaits FDA Decisions, More IPOs
Biotech stocks were down for a second week in a row, as they retreated along with the broader market amid macro concerns. Consumer price inflation data released during the week... 
Via Benzinga
Exposures Product Safety
Ligand to Report Second Quarter Financial Results on July 29, 2021
From Ligand Pharmaceuticals Incorporated
Via Business Wire
Ligand Pharmaceuticals Appoints Dr. Jennifer Cochran to its Board of Directors
From Ligand Pharmaceuticals Incorporated
Via Business Wire
Attention Biotech Investors: Mark Your Calendar For July PDUFA Dates
June was a month of plenty and also turned out to be a fruitful one from the perspective of Food and Drug Administration approvals. Regulatory reviews mostly produced positive... 
Via Benzinga
When Cap-Weighted Small-Cap Funds Own “Meme” Stocks
I cannot say whether GameStop or the other meme stocks will get their businesses back on their feet. What I can say is that, if you are tracking various small-cap indexes, you just might own them, like... 
Via Talk Markets
Ligand's Revenue Soars in Q1 Thanks to Gilead's COVID Drug
The drugmaker is also looking for its highest sales ever in 2021 in large part because of remdesivir. 
Via The Motley Fool
Ligand Pharmaceuticals Inc (LGND) Q1 2021 Earnings Call Transcript
LGND earnings call for the period ending March 31, 2021. 
Via The Motley Fool
Topics Earnings
Exposures Financial
The Daily Biotech Pulse: Vaxart Rebounds On Strong Vaccine Data, Pfizer's Beat-And-Raise Quarter, BioLineRx Data
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 3) AbbVie Inc. (NYSE: ABBV)... 
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
Gainers Precipio (NASDAQ: 
Via Benzinga
Recap: Ligand Pharmaceuticals Q1 Earnings
Shares of Ligand Pharmaceuticals (NASDAQ:LGND) fell 7% in after-market trading after the company reported Q1 results. Quarterly Results Earnings per share were up 58.43% over the... 
Via Benzinga
Ligand Reports First Quarter 2021 Financial Results
From Ligand Pharmaceuticals Incorporated
Via Business Wire
Short Interest Report: B&G Foods Short Position At Three-Month Highs
Estimated short interest in B&G Foods has accelerated its gains, spiking on Monday and also rising for four out of five trading sessions. For the week, B&G Foods short interest was up 22% at 28.94% of... 
Via Talk Markets
Ligand to Report First Quarter Financial Results on May 3, 2021
From Ligand Pharmaceuticals Incorporated
Via Business Wire
Earnings Scheduled For May 3, 2021
Companies Reporting Before The Bell • Scienjoy Holding (NASDAQ:SJ) is estimated to report quarterly earnings at $0.58 per share on revenue of $540.11 million. •... 
Via Benzinga
3 Signs the Ligand Short Squeeze Is Over
The Reddit crowd wasn't the only reason short-sellers got burned betting against this pharmaceutical company. 
Via The Motley Fool
< Previous 1 2 3 4 5 6 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.